| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 103 / 151 | 32nd | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Hematology
Advances in Hematology is Scopus-indexed (Q3, CiteScore 1.6), DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 1687-9104Verify ISSN ↗1687-9112Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Advances in Hematology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q3, CiteScore 1.6.
What quartile is Advances in Hematology in Scopus?
Advances in Hematology is Q3 in Hematology (rank 103 of 151), by CiteScore 2025.
What is the impact factor of Advances in Hematology?
Advances in Hematology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.6, quartile Q3, 32nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.439, quartile Q3, with an H-index of 42.
How much does it cost to publish in Advances in Hematology?
The publisher lists an article processing charge of about US$860 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Advances in Hematology and what is its ISSN?
Advances in Hematology is published by John Wiley and Sons Ltd. Its print ISSN is 1687-9104 and its online ISSN is 1687-9112.
Is Advances in Hematology in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Advances in Hematology open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Advances in Hematology? — open metrics via OpenAlex
Advances in Hematology has an h-index of 49 and a 2-year mean of 1.38 citations per paper (OpenAlex). Its Scopus CiteScore is 1.6, quartile Q3. On 2-year citations it ranks #74 of 148 Scopus journals in Hematology.
Advances in Hematology published 34 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Advances in Hematology? — latest 98 articles, 2021–2026
In its latest 98 research articles (2021–2026), authors are most often from United States (25.9%), Ghana (5.4%) and Ethiopia (4.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Advances in Hematology? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (4.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 4.8 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.